Doxycycline Induces Fas/Fas Ligand-Mediated Apoptosis in Jurkat T Lymphocytes
Authors:
- B.Timothy BaxterBBB.Timothy Baxter
- 1 July 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 260 (2) , 562-567
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Release of preformed Fas ligand in soluble form is the major factor for activation‐induced death of Jurkat T cellsImmunology, 1996
- Cellular Components and Features of Immune Response in Abdominal Aortic AneurysmsaAnnals of the New York Academy of Sciences, 1996
- Fas and FasL in the homeostatic regulation of immune responsesImmunology Today, 1995
- Human Vascular Smooth Muscle Cell–Monocyte Interactions and Metalloproteinase Secretion in CultureArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Inflammation and Matrix Metalloproteinases in the Enlarging Abdominal Aortic AneurysmArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationNature, 1995
- Doxycycline and Chemically Modified Tetracyclines Inhibit Gelatinase A (MMP‐2) Gene Expression in Human Skin KeratinocytesAnnals of the New York Academy of Sciences, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992